KPIs and Dashboards Used to Demonstrate PV System Control KPIs and Dashboards Used to Demonstrate PV System Control Pharmacovigilance (PV) plays a crucial role in ensuring drug safety and minimizing risks associated with pharmaceutical products. Regulatory Affairs (RA) professionals are tasked with adhering to Good Pharmacovigilance Practices (GVP) guidelines to maintain compliance with both local and international regulations. This article provides a detailed exploration of the key performance indicators (KPIs) and dashboards utilized to demonstrate control over PV systems, aligning with global regulatory standards from agencies such as the FDA, EMA, and MHRA. Context: Regulatory Framework for Pharmacovigilance The significance…

Managing Health Authority Follow-Up and Progress Updates Post-Inspection Managing Health Authority Follow-Up and Progress Updates Post-Inspection Context Pharmacovigilance (PV) is an essential component of drug safety and risk management, ensuring that medicinal products are monitored for adverse effects and overall safety profiles. The regulatory landscape surrounding pharmacovigilance is informed by guidelines established by health authorities such as the FDA, EMA, and MHRA, as well as global standards set by ICH. In the event of a health authority inspection, companies must efficiently manage follow-up actions and progress updates to ensure compliance with these regulations. This article details the expectations and processes…

Communication Plans for Senior Leadership During PV Crises Communication Plans for Senior Leadership During PV Crises Pharmacovigilance (PV) plays a critical role in drug safety and risk management. It is essential that regulatory affairs (RA) professionals, particularly those involved with pharmacovigilance compliance, develop effective communication plans to guide senior leadership during PV crises. This article aims to serve as a regulatory explainer manual, detailing relevant regulations, guidelines, and expectations surrounding the communication that must occur during adverse event reporting and crisis management in the US, UK, and EU. Context Pharmacovigilance refers to the science of monitoring the safety of pharmaceutical…

Lessons Learned from High-Profile PV Failures and Enforcement Actions Lessons Learned from High-Profile PV Failures and Enforcement Actions Pharmacovigilance (PV) plays a critical role in ensuring drug safety and risk management throughout the product lifecycle. With regulatory authorities across the globe demanding rigorous adherence to Good Pharmacovigilance Practices (GVP), the consequences of failures in pharmacovigilance systems can be severe, leading to enforcement actions and significant reputational damage. This article aims to provide a structured explanation of relevant regulations, guidelines, and expectations around pharmacovigilance systems in the US, UK, and EU, while elucidating the key lessons learned from high-profile failures. Context…

Designing Training and Change Management as Part of PV Remediation Designing Training and Change Management as Part of PV Remediation Context The pharmaceutical and biotechnology industry faces multiple challenges regarding pharmacovigilance (PV) compliance. Regulatory authorities, including the FDA in the US, EMA in the EU, and MHRA in the UK, stress the importance of robust PV systems to ensure drug safety and risk management. Compliance with Good Pharmacovigilance Practices (GVP) is paramount, particularly after identifying deficiencies through inspections or audits. Legal/Regulatory Basis Regulatory compliance consulting revolves around understanding and applying various legal frameworks that govern pharmacovigilance. Key documents and regulations…

Local vs Global PV Audits: Coordinating Scope, Tools and Findings Local vs Global PV Audits: Coordinating Scope, Tools and Findings Context Pharmacovigilance (PV) plays a critical role in ensuring drug safety and risk management throughout a product’s lifecycle. Organizations must maintain compliance with various global regulations, including GVP guidelines, which govern how adverse events are reported and analyzed. Conducting regular audits is vital for organizations to verify adherence to these standards and enhance their pharmacovigilance systems. This article provides a comprehensive overview of local versus global pharmacovigilance audits and the considerations necessary for regulatory compliance consulting services, particularly for professionals…

How RA, QA and PV Should Collaborate Before and During Inspections How RA, QA and PV Should Collaborate Before and During Inspections Regulatory Affairs Context In the highly regulated pharmaceutical industry, collaboration among various departments is crucial for ensuring compliance with established guidelines, especially during inspections. Regulatory Affairs (RA), Quality Assurance (QA), and Pharmacovigilance (PV) are three integral components that must work together to uphold the integrity of drug safety and risk management. This article explores how these departments can align their efforts to streamline the inspection process and ensure adherence to Good Pharmacovigilance Practices (GVP). Legal and Regulatory Basis…

Using Digital Tools to Track Inspection Actions and CAPA Closure Using Digital Tools to Track Inspection Actions and CAPA Closure Regulatory Affairs Context In the realm of pharmaceutical and biotech, regulatory affairs (RA) serve as a critical bridge between clinical development and market authorization. Within this context, pharmacovigilance (PV) focuses on the safety and efficacy of drug products post-marketing. These components are influenced by robust regulations and guidelines aimed at ensuring drug safety and risk management. The introduction of digital tools within RA not only enhances productivity but also ensures compliance with Good Pharmacovigilance Practices (GVP). This article seeks to…

Case Studies: Turning a Weak PV System into a Strength in 18–24 Months Case Studies: Turning a Weak PV System into a Strength in 18–24 Months In the ever-evolving field of Pharmacovigilance (PV), regulatory compliance is crucial for drug safety and risk management. Regulatory Affairs (RA) professionals, particularly those focused on pharmacovigilance compliance, play a key role in ensuring that safety data is collected, analyzed, and reported in accordance with applicable guidelines and regulations. This article will delve into the regulatory framework guiding PV and offer insights into how organizations can strengthen their systems and processes through case studies. Context…

Future Inspection Trends: Topics PV Leaders Need to Prepare For Now Future Inspection Trends: Topics PV Leaders Need to Prepare For Now In the rapidly evolving field of pharmacovigilance (PV), regulatory compliance audits are pivotal in ensuring that pharmaceutical companies adhere to established guidelines and maintain high standards of drug safety and risk management. As global regulatory authorities—including the FDA, EMA, and MHRA—continue to adapt their inspection processes in response to emerging trends and technological developments, it becomes imperative for PV leaders to remain attentive and proactive. This article explores the regulatory context, provides detailed insights into guidelines and agency…